<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Tranexamic acid for upper gastrointestinal bleeding - Bennett, C - 2014 | Cochrane Library</title> <meta content="Tranexamic acid for upper gastrointestinal bleeding - Bennett, C - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006640.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Tranexamic acid for upper gastrointestinal bleeding - Bennett, C - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006640.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006640.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Tranexamic acid for upper gastrointestinal bleeding" name="citation_title"/> <meta content="Cathy Bennett" name="citation_author"/> <meta content="Coventry University" name="citation_author_institution"/> <meta content="Sarah Louise Klingenberg" name="citation_author"/> <meta content="Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital" name="citation_author_institution"/> <meta content="Ebbe Langholz" name="citation_author"/> <meta content="Gentofte University Hospital" name="citation_author_institution"/> <meta content="Lise Lotte Gluud" name="citation_author"/> <meta content="Copenhagen University Hospital Hvidovre" name="citation_author_institution"/> <meta content="liselottegluud@yahoo.dk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD006640.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/11/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006640.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006640.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006640.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Aluminum Hydroxide [therapeutic use]; Anti‐Ulcer Agents [therapeutic use]; Antifibrinolytic Agents [adverse effects, *therapeutic use]; Cimetidine [therapeutic use]; Drug Combinations; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrhage [*drug therapy, mortality]; Injections, Intravenous; Lansoprazole [therapeutic use]; Magnesium [therapeutic use]; Magnesium Hydroxide [therapeutic use]; Randomized Controlled Trials as Topic; Tranexamic Acid [adverse effects, *therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006640.pub3&amp;doi=10.1002/14651858.CD006640.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006640\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006640\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ru","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006640.pub3",title:"Tranexamic acid for upper gastrointestinal bleeding",firstPublishedDate:"Nov 21, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006640.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006640.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006640.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006640.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006640.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006640.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006640.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006640.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006640.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006640.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>15595 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006640.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-sec-0103"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-sec-0062"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-sec-0097"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/appendices#CD006640-sec-0108"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/table_n/CD006640StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/table_n/CD006640StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Tranexamic acid for upper gastrointestinal bleeding</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information#CD006640-cr-0002">Cathy Bennett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information#CD006640-cr-0003">Sarah Louise Klingenberg</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information#CD006640-cr-0004">Ebbe Langholz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information#CD006640-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Lise Lotte Gluud</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information/en#CD006640-sec-0117">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 November 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006640.pub3">https://doi.org/10.1002/14651858.CD006640.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006640-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006640-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006640-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006640-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006640-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006640-abs-0002">繁體中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006640-abs-0001" lang="en"> <section id="CD006640-sec-0001"> <h3 class="title" id="CD006640-sec-0001">Background</h3> <p>Tranexamic acid reduces haemorrhage through its antifibrinolytic effects. In a previous version of the present review, we found that tranexamic acid may reduce mortality. This review includes updated searches and new trials. </p> </section> <section id="CD006640-sec-0002"> <h3 class="title" id="CD006640-sec-0002">Objectives</h3> <p>To assess the effects of tranexamic acid versus no intervention, placebo or other antiulcer drugs for upper gastrointestinal bleeding. </p> </section> <section id="CD006640-sec-0003"> <h3 class="title" id="CD006640-sec-0003">Search methods</h3> <p>We updated the review by performing electronic database searches (Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Science Citation Index) and manual searches in July 2014. </p> </section> <section id="CD006640-sec-0004"> <h3 class="title" id="CD006640-sec-0004">Selection criteria</h3> <p>Randomised controlled trials, irrespective of language or publication status.</p> </section> <section id="CD006640-sec-0005"> <h3 class="title" id="CD006640-sec-0005">Data collection and analysis</h3> <p>We used the standard methodological procedures of the The Cochrane Collaboration. All‐cause mortality, bleeding and adverse events were the primary outcome measures. We performed fixed‐effect and random‐effects model meta‐analyses and presented results as risk ratios (RRs) with 95% confidence intervals (CIs) and used I² as a measure of between‐trial heterogeneity. We analysed tranexamic acid versus placebo or no intervention and tranexamic acid versus antiulcer drugs separately. To analyse sources of heterogeneity and robustness of the overall results, we performed subgroup, sensitivity and sequential analyses. </p> </section> <section id="CD006640-sec-0006"> <h3 class="title" id="CD006640-sec-0006">Main results</h3> <p>We included eight randomised controlled trials on tranexamic acid for upper gastrointestinal bleeding. Additionally, we identified one large ongoing pragmatic randomised controlled trial from which data are not yet available. Control groups were randomly assigned to placebo (seven trials) or no intervention (one trial). Two trials also included a control group randomly assigned to antiulcer drugs (lansoprazole or cimetidine). The included studies were published from 1973 to 2011. The number of participants randomly assigned ranged from 47 to 216 (median 204). All trials reported mortality. In total, 42 of 851 participants randomly assigned to tranexamic acid and 71 of 850 in the control group died (RR 0.60, 95% CI 0.42 to 0.87; P value 0.007; I² = 0%). The analysis was not confirmed when all participants in the intervention group with missing outcome data were included as treatment failures, or when the analysis was limited to trials with low risk of attrition bias. Rebleeding was diagnosed for 117 of 826 participants in the tranexamic acid group and for 146 of 825 participants in the control group (RR 0.80, 95% CI 0.64 to 1.00; P value 0.07; I² = 49%). We were able to evaluate the risk of serious adverse events on the basis of only four trials. Our analyses showed 'no evidence of a difference between tranexamic acid and control interventions regarding the risk of thromboembolic events.' Tranexamic acid appeared to reduce the risk of surgery in a fixed‐effect meta‐analysis (RR 0.73, 95% CI 0.56 to 0.95), but this result was no longer statistically significant in a random‐effects meta‐analysis (RR 0.61, 95% CI 0.35 to 1.04; P value 0.07). No difference was apparent between tranexamic acid and placebo in the assessment of transfusion (RR 1.02, 95% CI 0.94 to 1.11; I² = 0%), and meta‐analyses that compared tranexamic acid versus antiulcer drugs did not identify beneficial or detrimental effects of tranexamic acid for any of the outcomes assessed. </p> </section> <section id="CD006640-sec-0007"> <h3 class="title" id="CD006640-sec-0007">Authors' conclusions</h3> <p>This review found that tranexamic acid appears to have a beneficial effect on mortality, but a high dropout rate in some trials means that we cannot be sure of this until the findings of additional research are published. At the time of this update in 2014, one large study (8000 participants) is in progress, so this review will be much more informative in a few years. Further examination of tranexamic acid would require inclusion of high‐quality randomised controlled trials. Timing of randomisation is essential to avoid attrition bias and to limit the number of withdrawals. Future trials may use a pragmatic design and should include all participants with suspected bleeding or with endoscopically verified bleeding, as well as a tranexamic placebo arm and co‐administration of pump inhibitors and endoscopic therapy. Assessment of outcome measures in such studies should be clearly defined. Endoscopic examination with appropriate control of severe bleeding should be performed, as should endoscopic verification of clinically significant rebleeding. In addition, clinical measures of rebleeding should be included. Other important outcome measures include mortality (30‐day or in‐hospital), need for emergency surgery or blood transfusion and adverse events (major or minor). </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006640-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006640-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006640-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006640-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006640-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006640-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006640-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006640-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006640-abs-0004" lang="en"> <h3>Tranexamic acid, an agent that promotes blood clotting, for serious or uncontrolled upper gastrointestinal bleeding </h3> <p><b>Background</b> </p> <p>Upper gastrointestinal bleeding is a common reason for emergency hospital admission. The prognosis is serious. Some patients may die as the result of uncontrolled bleeding. </p> <p><b>Review question</b> </p> <p>Tranexamic acid is an antifibrinolytic agent. This drug reduces the breakdown of fibrin; fibrin provides the framework for the formation of a blood clot, which is needed to stop the bleeding. Clinical trials suggest that tranexamic acid could reduce mortality in upper gastrointestinal bleeding. </p> <p><b>Study characteristics</b> </p> <p>This review includes data from eight randomised trials on tranexamic acid. Two trials also assessed antiulcer drugs. Only one trial used additional endoscopic therapy, as the remaining trials were performed before this intervention was introduced into clinical practice. </p> <p><b>Key results</b> </p> <p>These trials found that tranexamic acid appears to have a beneficial effect on mortality, but a high dropout rate in some trials means that we cannot be sure of these findings until additional research is published . Tranexamic acid did not reduce mortality in the trials that included antiulcer drugs or endoscopic therapy. Additional randomised controlled trials are needed before we can determine whether tranexamic acid has a beneficial effect on serious or uncontrolled upper gastrointestinal bleeding. </p> <p><b>Quality of the evidence</b> </p> <p>Many patients who were randomly assigned were subsequently excluded from the assessment. The main source of bias was therefore attrition. The overall quality of the evidence was moderate to low. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006640-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006640-sec-0103"></div> <h3 class="title" id="CD006640-sec-0104">Implications for practice</h3> <section id="CD006640-sec-0104"> <p>This review found no evidence to support or refute the use of tranexamic acid for upper gastrointestinal bleeding, in terms of mortality, bleeding, surgery or transfusion requirements. We found limited information about adverse events. At present, tranexamic acid cannot be recommended for routine clinical practice. </p> </section> <h3 class="title" id="CD006640-sec-0105">Implications for research</h3> <section id="CD006640-sec-0105"> <p>This review found no evidence that tranexamic acid offers benefit to patients with upper gastrointestinal bleeding in terms of mortality, bleeding, surgery or requirement for blood transfusion. At the time of this update in 2014, additional large pragmatic randomised trials seem warranted. We are aware of one large study (8000 participants) that is in progress, so this review will be much more informative in a few years. However, proton pump inhibitors and endoscopic interventions for severe gastrointestinal bleeding, including injection and thermal and mechanical methods such as haemoclips, may serve as alternative effective interventions (<a href="./references#CD006640-bbs2-0021" title="DworzynskiK , PollitV , KelseyA , HigginsB , PalmerK . Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ (Clinical Research Edition)2012;344:e3412. [PUBMED: 22695897] ">Dworzynski 2012</a>). </p> <p>Further examination of the efficacy and safety of tranexamic acid would involve high‐quality randomised controlled trials. The timing of randomisation is essential in avoiding attrition bias and limiting the number of withdrawals. The trial may use a pragmatic design and include all participants with suspected bleeding based on haemoglobin levels, gastric lavage, hematemesis or melena. Alternatively, only participants with endoscopically verified bleeding may be randomly assigned. The pragmatic approach could mean inclusion of participants with concomitant disease who may have higher risk of bleeding. When such participants are excluded from trials, we may overestimate benefits and underestimate adverse events. Therefore the advantage of a pragmatic approach would be that investigators could assess whether the intervention works in these patients, that is, such trials would have high external validity. </p> <p>Future trials should assess tranexamic acid delivered orally or intravenously over an appropriate length of time. The trials included in this review assessed a daily dose of up to 16 to 42 g. A placebo arm (for comparison with tranexamic acid) should be included, and interventions should be administered in accordance with current treatment recommendations. Accordingly, co‐interventions such as proton pump inhibitors and endoscopic therapy must be offered. Assessment of outcome measures should be clearly defined, and reports of adverse events should be included. Endoscopic examination with appropriate control of severe bleeding should be included, and endoscopic verification of clinically significant rebleeding should be performed. In addition, clinical measures of rebleeding should be included. Other important outcome measures include mortality (30‐day or in‐hospital), along with need for emergency surgery, blood transfusion and adverse events (major or minor). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006640-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006640-sec-0029"></div> <div class="table" id="CD006640-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Tranexamic acid vs placebo for upper gastrointestinal bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Tranexamic acid vs placebo for upper gastrointestinal bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with upper gastrointestinal bleeding<br/> <b>Settings:</b> <br/> <b>Intervention:</b> tranexamic acid vs placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Tranexamic acid vs placebo</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality</b> <br/> Clinical<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.6</b> <br/> (0.42‐0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1701<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> <br/> (34‐72) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> <br/> (34‐71) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Rebleeding</b> <br/> Clinical and endoscopic assessment<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.72</b> <br/> (0.50‐1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1651<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>177 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>142 per 1000</b> <br/> (113‐177) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>196 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>157 per 1000</b> <br/> (125‐196) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Any thromboembolic event</b> <br/> Clinical and radiological assessment<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.86</b> <br/> (0.66‐5.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1095<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> <br/> (7‐57) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> <br/> (7‐52) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Surgery</b> <br/> Number of participants who underwent surgery<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.61</b> <br/> (0.35‐1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1551<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>142 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> <br/> (79‐135) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>154 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>112 per 1000</b> <br/> (86‐146) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Transfusion</b> <br/> Number needing blood transfusion<br/> Follow‐up: median 3 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.02</b> <br/> (0.94‐1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>931<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>564 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>558 per 1000</b> <br/> (507‐620) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>583 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>577 per 1000</b> <br/> (525‐641) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Most trials had high risk of attrition bias.<br/> <sup>b</sup>Not possible to evaluate because number of trials was limited.<br/> <sup>c</sup>Statistical between‐trial heterogeneity approached 50%.<br/> <sup>d</sup>The number of participants who needed transfusion is an indirect measure of bleeding and varies among clinical sites. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006640-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Tranexamic acid vs cimetidine or lansoprazole for upper gastrointestinal bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Tranexamic acid vs cimetidine or lansoprazole for upper gastrointestinal bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with upper gastrointestinal bleeding<br/> <b>Settings:</b> <br/> <b>Intervention:</b> tranexamic acid vs cimetidine or lansoprazole </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Tranexamic acid vs cimetidine or lansoprazole</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality</b> <br/> Number of participants who died<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.91</b> <br/> (0.50‐1.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>720<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> <br/> (31‐101) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b> <br/> (24‐79) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Rebleeding</b> <br/> Clinical and endoscopic assessment<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.87</b> <br/> (0.64‐1.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>720<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>188 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>166 per 1000</b> <br/> (121‐226) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>161 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>142 per 1000</b> <br/> (103‐193) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Surgery</b> <br/> Number of participants who underwent surgery<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.83</b> <br/> (0.54‐1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>720<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>139 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>115 per 1000</b> <br/> (79‐168) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>87 per 1000</b> <br/> (60‐127) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Transfusion</b> <br/> Number of participants who required at least 1 blood transfusion<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.97</b> <br/> (0.78‐1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>720<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>573 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>579 per 1000</b> <br/> (510‐654) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>599 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>605 per 1000</b> <br/> (533‐683) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>High risk of bias based on assessment of attrition.<br/> <sup>b</sup>Not possible to evaluate because number of trials was limited.<br/> <sup>c</sup>This outcome measure is a surrogate estimate for bleeding. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006640-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006640-sec-0030"></div> <section id="CD006640-sec-0031"> <h3 class="title" id="CD006640-sec-0031">Description of the condition</h3> <p>Upper gastrointestinal bleeding is a common reason for emergency hospital admission and a common complication in hospitalised patients (<a href="./references#CD006640-bbs2-0040" title="RockallTA , LoganRF , DevlinHB , NorthfieldTC . Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ (Clinical Research Edition)1995;311:222‐6. ">Rockall 1995</a>; <a href="./references#CD006640-bbs2-0018" title="BlatchfordO , DavidsonLA , MurrayWR , BlatchfordM , PellJ . Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ (Clinical Research Edition)1997;315:510‐4. ">Blatchford 1997</a>). A systematic review of general, population‐based epidemiological studies found that the incidence of upper gastrointestinal bleeding among patients treated with non‐steroidal anti‐inflammatory drugs was 0.8 per 1000 (<a href="./references#CD006640-bbs2-0027" title="Hernandez‐DiazS , RodriguezLA . Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies. Journal of Clinical Epidemiology2002;55:157‐63. ">Hernandez 2002</a>). The risk of upper gastrointestinal bleeding has been found to increase significantly with age, co‐morbidity and use of non‐steroidal anti‐inflammatory drugs (<a href="./references#CD006640-bbs2-0047" title="YavorskiRT , WongRK , MaydonovitchC , BattinLS , FurniaA , AmundsonDE . Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. American Journal of Gastroenterology1995;90:568‐73. ">Yavorski 1995</a>; <a href="./references#CD006640-bbs2-0038" title="PaspatisGA , MatrellaE , KapsoritakisA , LeontithisC , PapanikolaouN , ChlouverakisGJ , et al. An epidemiological study of acute upper gastrointestinal bleeding in Crete, Greece. European Journal of Gastroenterology &amp; Hepatology2000;12:1215‐20. ">Paspatis 2000</a>; <a href="./references#CD006640-bbs2-0036" title="NgW , WongWM , ChenWH , TseHF , LeePY , LaiKC , et al. Incidence and predictors of upper gastrointestinal bleeding in patients receiving low‐dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease. World Journal of Gastroenterology2006;12:2923‐7. ">Ng 2006</a>). About 80% of patients with upper gastrointestinal bleeding will spontaneously stop bleeding, without recurrence (<a href="./references#CD006640-bbs2-0031" title="LaineL , PetersonWL . Bleeding peptic ulcer. New England Journal of Medicine1994;331(11):717‐27. [PUBMED: 8058080] ">Laine 1994</a>). The highest mortality and morbidity rates are seen in the remaining 20%, who experience recurrent or continued bleeding. Among patients referred to endoscopy for suspected upper gastrointestinal bleeding, 30‐day mortality is 10% to 14% (<a href="./references#CD006640-bbs2-0043" title="vanLeerdamME , VreeburgEM , RauwsEA , GeraedtsAA , TijssenJG , ReitsmaJB , et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. The American Journal of Gastroenterology2003;98(7):1494‐9. [PUBMED: 12873568] ">van Leerdam 2003</a>; <a href="./references#CD006640-bbs2-0016" title="BarkunA , SabbahS , EnnsR , ArmstrongD , GregorJ , FedorakRN , et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real‐life setting. The American Journal of Gastroenterology2004;99(7):1238‐46. [PUBMED: 15233660] ">Barkun 2004</a>; <a href="./references#CD006640-bbs2-0017" title="BarkunAN , BardouM , KuipersEJ , SungJ , HuntRH , MartelM , SinclairP , International Consensus Upper Gastrointestinal Bleeding Conference Group. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Annals of Internal Medicine2010;152:101‐13. ">Barkun 2010</a>). </p> </section> <section id="CD006640-sec-0032"> <h3 class="title" id="CD006640-sec-0032">Description of the intervention</h3> <p>Several endoscopic therapies have been found to be effective in clinical trials (<a href="./references#CD006640-bbs2-0030" title="KahiCJ , JensenDM , SungJJ , BleauBL , JungHK , EckertG , et al. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta‐analysis. Gastroenterology2005;129:855‐62. ">Kahi 2005</a>). However, some hospital departments may not have access to acute endoscopy. In other cases, patients may refuse to undergo endoscopy. Identification of drugs that may achieve haemostasis, stabilising patients until endoscopy can be performed, is therefore essential. </p> </section> <section id="CD006640-sec-0033"> <h3 class="title" id="CD006640-sec-0033">How the intervention might work</h3> <p>Tranexamic acid reduces fibrinolysis by slowing down the conversion of plasminogen to plasmin. The resulting reduction in fibrinolysis prevents the breakdown of blood clots, which may result in haemostasis but increased risk of thromboembolic complications. This drug was introduced for menorrhagia in 1968 (<a href="./references#CD006640-bbs2-0044" title="VermylenJ , Verhaegen‐DeclercqML , FierensF , VerstraeteM . A double blind study of the effect of tranexamic acid in essential menorrhagia. Bulletin de la Société Royale Belge de Gynécologie et D'Obstétrique1968;38:385‐90. ">Vermylen 1968</a>) and is used to reduce blood loss during surgery (<a href="./references#CD006640-bbs2-0033" title="LaupacisA , FergussonD . Drugs to minimize perioperative blood loss in cardiac surgery: meta‐analyses using perioperative blood transfusion as the outcome. The International Study of Peri‐operative Transfusion (ISPOT) Investigators. Anesthesia and Analgesia1997;85:1258‐67. ">Laupacis 1997</a>; <a href="./references#CD006640-bbs2-0019" title="CidJ , LozanoM . Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta‐analysis of randomized controlled trials. Transfusion2005;45:1302‐7. ">Cid 2005</a>). A large multi‐centre trial found that tranexamic acid reduces mortality in individuals with bleeding trauma by 9% and results in no apparent increase in thromboembolic events (<a href="./references#CD006640-bbs2-0020" title="CRASH‐2 Collaborators. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH‐2 Intracranial Bleeding Study). BMJ (Clinical Research Edition)2011;343:d3795. [PUBMED: 21724564] ">CRASH‐2</a>). It is possible that a similar effect can be achieved in cases of upper gastrointestinal bleeding. </p> </section> <section id="CD006640-sec-0034"> <h3 class="title" id="CD006640-sec-0034">Why it is important to do this review</h3> <p>Endoscopic therapy and proton pump inhibitors serve as the cornerstone in the treatment of bleeding from peptic ulcers (<a href="./references#CD006640-bbs2-0032" title="LauJY , BarkunA , FanDM , KuipersEJ , YangYS , ChanFK . Challenges in the management of acute peptic ulcer bleeding. Lancet2013;381(9882):2033‐43. [PUBMED: 23746903] ">Lau 2013</a>). These treatments are highlighted in recent evidence‐based guidelines (<a href="./references#CD006640-bbs2-0021" title="DworzynskiK , PollitV , KelseyA , HigginsB , PalmerK . Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ (Clinical Research Edition)2012;344:e3412. [PUBMED: 22695897] ">Dworzynski 2012</a>), which do not recommend tranexamic acid for the management of upper gastrointestinal bleeding. Randomised trials have assessed the effects of tranexamic acid among patients with suspected or verified upper gastrointestinal bleeding (<a href="./references#CD006640-bbs2-0005" title="CormackF , ChakrabartiRR , JouharAJ , FearnleyGR . Tranexamic acid in upper gastrointestinal haemorrhage. Lancet1973;1:1207‐8. ">Cormack 1973</a>; <a href="./references#CD006640-bbs2-0004" title="BiggsJC , HughTB , DoddsAJ . Tranexamic acid and upper gastrointestinal haemorrhage ‐ a double‐blind trial. Gut1976;17:729‐34. ">Biggs 1976</a>; <a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a>; <a href="./references#CD006640-bbs2-0003" title="BergqvistD , DahlgrenS , HessmanY . Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Uppsala Journal of Medical Sciences1980;85:173‐8. ">Bergqvist 1980</a>; <a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a>; <a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). A meta‐analysis of these trials revealed that tranexamic acid reduces the risks of rebleeding and mortality (<a href="./references#CD006640-bbs2-0026" title="HenryDA , O'ConnellDL . Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ (Clinical Research Edition)1989;298:1142‐6. ">Henry 1989</a>). However, results of individual trials varied considerably. Furthermore, the overall result has been characterised as disproportionately skewed by inclusion of a trial in which mortality in the control group was surprisingly high (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0037" title="PalmerKR . Non‐variceal upper gastrointestinal haemorrhage: guidelines. Gut2002;Suppl 4:1‐6. ">Palmer 2002</a>). We have previously published a systematic review on tranexamic acid versus placebo (<a href="./references#CD006640-bbs2-0048" title="GluudLL , KlingenbergSL , LangholzE . Systematic review: tranexamic acid for upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2008;27:752‐8. ">Gluud 2008</a>). A randomised trial on tranexamic acid for upper gastrointestinal bleeding was published after our previous meta‐analysis had been completed (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). This trial was included in a recent review, which determined that we still have insufficient evidence for definitive conclusions (<a href="./references#CD006640-bbs2-0035" title="MannoD , KerK , RobertsI . How effective is tranexamic acid for acute gastrointestinal bleeding?. BMJ (Clinical Research Edition)2014;348:g1421. [PUBMED: 24535627] ">Manno 2014</a>). We performed this updated systematic review on tranexamic acid versus placebo, cimetidine or lansoprazole for upper gastrointestinal bleeding. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006640-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006640-sec-0035"></div> <p>To assess the effects of tranexamic acid versus no intervention, placebo or other antiulcer drugs for upper gastrointestinal bleeding. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006640-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006640-sec-0036"></div> <section id="CD006640-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006640-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised trials, irrespective of language, blinding, length of follow‐up or publication status. </p> </section> <section id="CD006640-sec-0039"> <h4 class="title">Types of participants</h4> <p>Individuals with suspected or endoscopically verified upper gastrointestinal bleeding, irrespective of the bleeding source. </p> </section> <section id="CD006640-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Primary analyses included trials on tranexamic acid versus placebo or no intervention. Secondary analyses compared tranexamic acid versus any other antiulcer drug. </p> </section> <section id="CD006640-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD006640-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD006640-list-0001"> <li> <p>Mortality.</p> </li> <li> <p>Adverse events. We defined serious adverse events as all adverse events considered serious by study participants or investigators. </p> </li> </ul> </p> </section> <section id="CD006640-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD006640-list-0002"> <li> <p>Rebleeding.</p> </li> <li> <p>Surgery.</p> </li> </ul> </p> </section> </section> </section> <section id="CD006640-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006640-sec-0045"> <h4 class="title">Electronic searches</h4> <p>Electronic searches of the following were performed July 2014.</p> <p> <ul id="CD006640-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) <b>(</b><a href="./appendices#CD006640-sec-0109">Appendix 1</a>). </p> </li> <li> <p>MEDLINE via Ovid SP (<a href="./appendices#CD006640-sec-0110">Appendix 2</a>). </p> </li> <li> <p>EMBASE via Ovid SP (<a href="./appendices#CD006640-sec-0111">Appendix 3</a>). </p> </li> <li> <p>Science Citation Index Expanded (<a href="./appendices#CD006640-sec-0112">Appendix 4</a>). </p> </li> </ul> </p> </section> <section id="CD006640-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We scanned conference proceedings and reference lists from relevant trials, wrote to authors of included trials and searched the International Clinical Trials Registry Platform (ICTRP) to identify trials on tranexamic acid (<a href="./appendices#CD006640-sec-0113">Appendix 5</a>). </p> </section> </section> <section id="CD006640-sec-0047"> <h3 class="title" id="CD006640-sec-0047">Data collection and analysis</h3> <section id="CD006640-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Three review authors (LLG, SLK and CB) screened search results for potentially eligible trials and identified trials that were eligible for inclusion. Excluded trials were listed together with the reasons for exclusion. At each stage of the selection process, at least two review authors independently reviewed search results and selected trials for inclusion. Three review authors (LLG, SLK and CB) agreed on the final list. </p> </section> <section id="CD006640-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LLG and SLK) independently extracted data using data collection forms designed to capture information specific to this review. CB verified the extracted data at this update. Disagreements were resolved through discussion before analyses were performed. Data on baseline participant characteristics (inclusion criteria, mean age, proportion of men and source of bleeding), dose and duration of treatment, country of origin, publication status, funding, duration of follow‐up and risk of bias were gathered from the included trials and from correspondence with study authors. For trials published in Russian, two review authors (LLG and CB) extracted data obtained by machine translation (Google translate). Dimitrinka Nikolova from the Cochrane Hepato‐Biliary Group read the original Russian language publication and verified the extracted data. </p> </section> <section id="CD006640-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>At least two review authors (LLG and SLK or CB) independently assessed risk of bias in the included studies by using the risk of bias assessment tool provided in Chapter 8 of the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006640-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). We compared these evaluations and discussed and resolved inconsistencies. </p> <p>We rated the following domains separately for each of the included studies as 'low risk of bias,' 'high risk of bias' or 'unclear risk of bias' if the risk of bias was uncertain or unknown. These assessments are reported in the 'Risk of bias' table for each individual study included in the <a href="./references#CD006640-sec-0123" title="">Characteristics of included studies</a> section of the review. </p> <p> <ul id="CD006640-list-0004"> <li> <p>Allocation sequence was adequately generated ('sequence generation').</p> </li> <li> <p>Allocation was adequately concealed ('allocation concealment').</p> </li> <li> <p>Knowledge of allocated interventions was adequately prevented during the study ('blinding') (whether the trial was described as double‐blind or single‐blind, and whether blinding involved healthcare providers, outcome assessors or those performing data extraction or data analysis). </p> </li> <li> <p>Incomplete outcome data were adequately addressed.</p> </li> <li> <p>Reports of the study were free of suggestions of selective outcome reporting (whether clinically relevant outcome measures were defined and reported). </p> </li> <li> <p>The study was apparently free of other sources of bias that could put it at high risk of bias (e.g. potential conflicts of interest, pharmaceutical funding/support, or both). </p> </li> <li> <p>Other biases (sample size calculations and registration in clinical trial databases).</p> </li> </ul> </p> <p>We categorised and reported the overall risk of bias of each of the included studies according to the following. </p> <p> <ul id="CD006640-list-0005"> <li> <p>Low risk of bias (plausible bias unlikely to seriously alter the results) if all criteria were met. </p> </li> <li> <p>Unclear risk of bias (plausible bias that raises some doubt about the results) if one or more criteria were assessed as unclear. </p> </li> <li> <p>High risk of bias (plausible bias that seriously weakens confidence in the results) if one or more criteria were not met. </p> </li> </ul> </p> <p>We reported these assessments in the <a href="#CD006640-sec-0074">Risk of bias in included studies</a> section of this review. </p> </section> <section id="CD006640-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>The effect measure consisted of risk ratios (RRs) with 95% confidence intervals (CIs).</p> </section> <section id="CD006640-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>As the primary outcome measure was mortality, only trials using a parallel‐group design were included. Data on all intervention groups were analysed separately for all trials, including those with more than two parallel arms. Risk of selection bias was noted in the allocation of participants to intervention or control groups and in the administration of collateral interventions; therefore we did not include cluster‐randomised trials. </p> <section id="CD006640-sec-0053"> <h5 class="title">Multi‐armed trials</h5> <p>For trials with multiple intervention groups, we partitioned participants into individual allocation arms to perform pair‐wise comparisons. For example, a three‐arm trial with 30 participants (10 in each arm) allocated to tranexamic acid versus placebo versus antiulcer drugs would allow two pair‐wise comparisons of tranexamic acid versus placebo (10 vs 10 participants) and tranexamic acid versus antiulcer drugs (10 vs 10 participants). </p> </section> </section> <section id="CD006640-sec-0054"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study investigators to request data on all randomly assigned participants to perform intention‐to‐treat analyses. We used simple imputation to evaluate the potential influence of missing data: imputing failures, imputing successes and worst‐ and best‐case scenarios (<a href="./references#CD006640-bbs2-0028" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Colloboration, 2008. www.cochrane‐handbook.org. ">Higgins 2008</a>). </p> </section> <section id="CD006640-sec-0055"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity by examining trial conditions on the basis of characteristics of included trials, participants and interventions. We assessed statistical heterogeneity by using I<sup>2</sup> statistical values and reported heterogeneity as important when the I² statistic was &gt; 60% (<a href="./references#CD006640-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD006640-sec-0056"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to obtain trial protocols to compare reported outcome measures in the protocol versus those in the published trial. For analyses with at least 10 trials, we planned to assess reporting biases and other dissemination biases by using funnel plots (<a href="./references#CD006640-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>) and to perform regression analyses by using Harbord's modified test (<a href="./references#CD006640-bbs2-0025" title="HarbordRM , EggerM , SterneJA . A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine2006;25(20):3443‐57. [PUBMED: 16345038] ">Harbord 2006</a>). Our analyses included only eight trials; therefore we did not carry out a statistical analysis of reporting bias. </p> </section> <section id="CD006640-sec-0057"> <h4 class="title">Data synthesis</h4> <p>We performed analyses in <a href="./references#CD006640-bbs2-0039" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a> (The Nordic Cochrane Centre, Copenhagen, Denmark), STATA version 13 (Stata Corp., Texas, USA) and Trial Sequential Analysis (The Cochrane Hepato‐Biliary Group, Copenhagen, Denmark). We performed all meta‐analyses using both random‐effects and fixed‐effect models. Fixed‐effect model meta‐analyses are reported only when the results of the two models differ (e.g. one model shows no difference between interventions and the other shows an intervention effect). </p> <p>We report the results of analyses with the total number of participants. When it was possible to calculate an effect size, we report this with 95% confidence intervals. When the calculated effect size was statistically significant (defined as P value &lt; 0.05), we state whether the result favoured the intervention or control condition. </p> </section> <section id="CD006640-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed separate analyses of trials on tranexamic acid versus placebo or no intervention and trials on tranexamic acid versus antiulcer drugs, as well as subgroup analyses of trials with low risk of bias based on assessment of the separate domains. We also analysed subgroups of trials that used endoscopic therapy and trials published in English or Russian. </p> </section> <section id="CD006640-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>We performed two further analyses to determine the effects of missing outcome data and a per‐protocol analysis to evaluate the influence of missing data. In the first scenario, all participants in the intervention arm with missing outcome data were included as treatment failures and participants in the control group with missing outcome data were considered as treatment successes. In the per‐protocol analyses, we excluded participants with missing outcome data. We performed a post hoc analysis that excluded a trial with a very high event rate in the control group (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>). </p> <section id="CD006640-sec-0060"> <h5 class="title">Trial sequential analysis</h5> <p>We performed a post hoc trial sequential analysis to determine the risk of bias associated with cumulative testing and to evaluate futility in the assessment of mortality and bleeding (<a href="./references#CD006640-bbs2-0028" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Colloboration, 2008. www.cochrane‐handbook.org. ">Higgins 2008</a>; <a href="./references#CD006640-bbs2-0045" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61:64‐75. ">Wetterslev 2008</a>). We performed the analysis with power set to 80%, alpha to 5% and model‐based diversity and with relative risk reduction (RRR) to 30%. We set the control incidence to 10% for the analysis of mortality and to 30% for the analysis of bleeding. </p> </section> <section id="CD006640-sec-0061"> <h5 class="title">'Summary of findings' tables</h5> <p>We prepared a 'Summary of findings' table (<a href="./references#CD006640-bbs2-0024" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical Research Edition)2008;336(7650):924‐6. [PUBMED: 18436948] ">Guyatt 2008</a>) using GRADEpro software (<a href="./references#CD006640-bbs2-0023" title="The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group. GRADEpro. [Computer program]. Version 3.2 for Windows. Jan Brozek, Andrew Oxman, Holger Schünemann, 2008. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group, 2008. ">Gradepro 3.6</a>) and we included information on the results of our primary outcomes in relation to risk of heterogeneity, duration of follow‐up and quality of the evidence. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006640-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006640-sec-0062"></div> <section id="CD006640-sec-0063"> <h3 class="title">Description of studies</h3> <section id="CD006640-sec-0064"> <h4 class="title">Results of the search</h4> <p>The original electronic searches identified 84 hits, and the updated search 37 hits (<a href="./appendices#CD006640-sec-0114">Appendix 6</a>). The manual search identified one additional record. After reading the titles and abstracts, we retrieved 15 records for further assessment. One record referred to an ongoing trial (<a href="./references#CD006640-bbs2-0013" title="Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial. ISRCTN2012. ">ISRCTN11225767</a>) on tranexamic acid for gastrointestinal bleeding (<a href="./references#CD006640-sec-0125" title="">Characteristics of ongoing studies</a>). We will include this trial in future updates if the results become available (<a href="#CD006640-fig-0001">Figure 1</a>). We excluded four records that did not assess tranexamic acid for upper gastrointestinal bleeding. In total, we included eight randomised controlled trials in our analyses (<a href="./references#CD006640-bbs2-0005" title="CormackF , ChakrabartiRR , JouharAJ , FearnleyGR . Tranexamic acid in upper gastrointestinal haemorrhage. Lancet1973;1:1207‐8. ">Cormack 1973</a>; <a href="./references#CD006640-bbs2-0004" title="BiggsJC , HughTB , DoddsAJ . Tranexamic acid and upper gastrointestinal haemorrhage ‐ a double‐blind trial. Gut1976;17:729‐34. ">Biggs 1976</a>; <a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a>; <a href="./references#CD006640-bbs2-0003" title="BergqvistD , DahlgrenS , HessmanY . Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Uppsala Journal of Medical Sciences1980;85:173‐8. ">Bergqvist 1980</a>; <a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a>; <a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>; <a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). We received additional information about study design and outcomes from the primary investigators of one of the included trials (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). For the remaining trials, we had access only to published data. The included trials were published as full paper articles, from 1973 to 2011. One trial was published in Russian (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>), and the remaining in English. </p> <div class="figure" id="CD006640-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006640-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD006640-sec-0065"> <h4 class="title">Included studies</h4> <section id="CD006640-sec-0066"> <h5 class="title">Design</h5> <p>All trials were randomised, parallel arm. One trial was open (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>), and the remaining trials were double blind with a placebo control. </p> </section> <section id="CD006640-sec-0067"> <h5 class="title">Sample sizes</h5> <p>The numbers of participants randomly assigned ranged from 47 to 216 (median 204).</p> </section> <section id="CD006640-sec-0068"> <h5 class="title">Setting</h5> <p>All trials were performed at hospitals.</p> </section> <section id="CD006640-sec-0069"> <h5 class="title">Participants</h5> <p>The trials included participants admitted with suspected upper gastrointestinal bleeding confirmed by endoscopy or clinically through gastric lavage, hematemesis or melena. Participants with previous or ongoing thromboembolic disease or renal disease and pregnant women were excluded from the trials. Three trials included only participants with severe bleeding (<a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a>; <a href="./references#CD006640-bbs2-0003" title="BergqvistD , DahlgrenS , HessmanY . Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Uppsala Journal of Medical Sciences1980;85:173‐8. ">Bergqvist 1980</a>; <a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). In the remaining trials, proportions of participants with circulatory involvement ranged from 1% to 21%. Mean participant age ranged from 56 to 62 years in the tranexamic acid groups and from 56 to 65 years in the control groups. Five trials reported that a proportion of participants had oesophageal varices (mean proportion 8%, range 5% to 16%). In four trials (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a>; <a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>; <a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>), participants underwent endoscopy within 24 hours after admission. One trial reported that 12% of included participants did not undergo the planned endoscopy. Two trials evaluated participants with endoscopy but did not specify the time frame (<a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a>; <a href="./references#CD006640-bbs2-0003" title="BergqvistD , DahlgrenS , HessmanY . Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Uppsala Journal of Medical Sciences1980;85:173‐8. ">Bergqvist 1980</a>). The remaining two trials did not include an endoscopic evaluation (<a href="./references#CD006640-bbs2-0005" title="CormackF , ChakrabartiRR , JouharAJ , FearnleyGR . Tranexamic acid in upper gastrointestinal haemorrhage. Lancet1973;1:1207‐8. ">Cormack 1973</a>) or had access to endoscopy only during a portion of the trial (<a href="./references#CD006640-bbs2-0004" title="BiggsJC , HughTB , DoddsAJ . Tranexamic acid and upper gastrointestinal haemorrhage ‐ a double‐blind trial. Gut1976;17:729‐34. ">Biggs 1976</a>). </p> </section> <section id="CD006640-sec-0070"> <h5 class="title">Interventions</h5> <p>Tranexamic acid was administered intravenously in one trial (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>) and orally in three trials (<a href="./references#CD006640-bbs2-0005" title="CormackF , ChakrabartiRR , JouharAJ , FearnleyGR . Tranexamic acid in upper gastrointestinal haemorrhage. Lancet1973;1:1207‐8. ">Cormack 1973</a>; <a href="./references#CD006640-bbs2-0003" title="BergqvistD , DahlgrenS , HessmanY . Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Uppsala Journal of Medical Sciences1980;85:173‐8. ">Bergqvist 1980</a>; <a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). The remaining trials used intravenous followed by oral administration. The total daily dose of tranexamic acid ranged from 4 to 8 g. Duration of therapy ranged from two to seven days. </p> </section> <section id="CD006640-sec-0071"> <h5 class="title">Comparisons</h5> <p>One trial included a no intervention control group (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>), and the remaining trials included a placebo control. Two trials were multi‐armed and included control groups randomly assigned to the histamine receptor (H2) agonist cimetidine (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>) or the proton pump inhibitor lansoprazole alone or with tranexamic acid (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). One trial allowed co‐intervention with the histamine receptor agonist famotidine (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). In five trials, a variety of co‐interventions, including novaluzide and cimetidine or ranitidine, were administered to participants in both treatment arms (<a href="./references#CD006640-bbs2-0005" title="CormackF , ChakrabartiRR , JouharAJ , FearnleyGR . Tranexamic acid in upper gastrointestinal haemorrhage. Lancet1973;1:1207‐8. ">Cormack 1973</a>; <a href="./references#CD006640-bbs2-0004" title="BiggsJC , HughTB , DoddsAJ . Tranexamic acid and upper gastrointestinal haemorrhage ‐ a double‐blind trial. Gut1976;17:729‐34. ">Biggs 1976</a>; <a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a>; <a href="./references#CD006640-bbs2-0003" title="BergqvistD , DahlgrenS , HessmanY . Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Uppsala Journal of Medical Sciences1980;85:173‐8. ">Bergqvist 1980</a>; <a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a>). Two trials used endoscopic therapy to control bleeding (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>; <a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). </p> </section> <section id="CD006640-sec-0072"> <h5 class="title">Outcomes</h5> <p>One trial reported endoscopically verified rebleeding (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). Another trial reported rebleeding as assessed by hematemesis, melena or hypotension plus a drop in haemoglobin or rebleeding seen at endoscopy (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). Two trials defined rebleeding on the basis of a drop in haemoglobin (<a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a>) or a drop in haemoglobin, hematemesis or melena (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>). The remaining trials did not define rebleeding. </p> </section> </section> <section id="CD006640-sec-0073"> <h4 class="title">Excluded studies</h4> <p>We excluded four trials that were published as full paper articles (<a href="./references#CD006640-bbs2-0010" title="HollandersD , ThomsonJM , SchofieldPF . Tranexamic acid therapy in ulcerative colitis. Postgraduate Medical Journal1982;58(676):87‐91. ">Hollanders 1982</a>; <a href="./references#CD006640-bbs2-0012" title="TamHC , LeeYC , WongHY , NgNS . Healing of gastric ulcer in the elderly: a double‐blind study of cetraxate versus ranitidine. Journal of Clinical Gastroenterology1989;11:183‐6. ">Tam 1989</a>; <a href="./references#CD006640-bbs2-0009" title="AdachiK , SuetsuguH , MoriyamaN , KazumoriH , KawamuraA , FujishiroH , et al. Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection‐induced ulcers. Journal of Gastroenterology and Hepatology2001;16:1211‐6. ">Adachi 2001</a>; <a href="./references#CD006640-bbs2-0011" title="SabovicM , LavreJ , VujkovacB . Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrology, Dialysis, Transplantation2003;18:1388‐91. ">Sabovic 2003</a>). These trials were excluded because they were observational, assessed certrexate or did not include participants with upper gastrointestinal bleeding (<a href="#CD006640-sec-0073">Excluded studies</a>). </p> </section> </section> <section id="CD006640-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD006640-sec-0075"> <h4 class="title">Allocation</h4> <p>One trial (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>) reported an adequate method for allocation sequence generation (<a href="#CD006640-fig-0002">Figure 2</a>). The remaining trials did not describe how the allocation sequence was generated. One trial did not describe how allocation was concealed (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). In the remaining trials, allocation was adequately concealed through double‐blind administration of the intervention or placebo. </p> <div class="figure" id="CD006640-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006640-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD006640-sec-0076"> <h4 class="title">Blinding</h4> <p>One trial was open (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). The remaining trials were double blind with a placebo control. </p> </section> <section id="CD006640-sec-0077"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition was one of the main sources of bias. Five trials reported losses to follow‐up (<a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a>; <a href="./references#CD006640-bbs2-0003" title="BergqvistD , DahlgrenS , HessmanY . Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Uppsala Journal of Medical Sciences1980;85:173‐8. ">Bergqvist 1980</a>; <a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a>; <a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). Three trials gave the impression that no dropouts or withdrawals had occurred, although this was not specifically reported (<a href="./references#CD006640-bbs2-0005" title="CormackF , ChakrabartiRR , JouharAJ , FearnleyGR . Tranexamic acid in upper gastrointestinal haemorrhage. Lancet1973;1:1207‐8. ">Cormack 1973</a>; <a href="./references#CD006640-bbs2-0004" title="BiggsJC , HughTB , DoddsAJ . Tranexamic acid and upper gastrointestinal haemorrhage ‐ a double‐blind trial. Gut1976;17:729‐34. ">Biggs 1976</a>; <a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). One in five participants (20%) were withdrawn or excluded after randomisation. Reasons for exclusion included lack of verified bleeding, malignant disease and terminal illness, or the treatment was administered too late. </p> </section> <section id="CD006640-sec-0078"> <h4 class="title">Selective reporting</h4> <p>One trial did not report bleeding and was classed as having high risk of reporting bias (<a href="./references#CD006640-bbs2-0003" title="BergqvistD , DahlgrenS , HessmanY . Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Uppsala Journal of Medical Sciences1980;85:173‐8. ">Bergqvist 1980</a>). </p> </section> <section id="CD006640-sec-0079"> <h4 class="title">Other potential sources of bias</h4> <p>None of the trials had other potential sources of bias.</p> </section> </section> <section id="CD006640-sec-0080"> <h3 class="title" id="CD006640-sec-0080">Effects of interventions</h3> <p>See: <a href="./full#CD006640-tbl-0001"><b>Summary of findings for the main comparison</b> Tranexamic acid vs placebo for upper gastrointestinal bleeding</a>; <a href="./full#CD006640-tbl-0002"><b>Summary of findings 2</b> Tranexamic acid vs cimetidine or lansoprazole for upper gastrointestinal bleeding</a> </p> <section id="CD006640-sec-0081"> <h4 class="title">Comparison 1. Tranexamic acid versus placebo</h4> <section id="CD006640-sec-0082"> <h5 class="title">Primary outcomes</h5> <section id="CD006640-sec-0083"> <h6 class="title">Mortality</h6> <p>All trials reported mortality (<a href="./references#CD006640-fig-0005" title="">Analysis 1.1</a>). Forty‐two of 851 participants randomly assigned to tranexamic acid and 71 of 850 in the control group died. The fixed‐effect meta‐analysis showed that tranexamic acid reduced mortality (RR 0.60, 95% CI 0.42 to 0.87; P value 0.007). No statistical heterogeneity was noted between trials (I² = 0%). </p> <section id="CD006640-sec-0084"> <p><b>Sensitivity analyses and trial sequential analysis</b></p> <p>The analysis was not confirmed in a scenario analysis in which all participants with missing outcome data were included as treatment failures (<a href="./references#CD006640-fig-0006" title="">Analysis 1.2</a>), but it was confirmed in a per‐protocol analysis (data not shown). </p> <p>Analyses of studies with low risk of bias confirmed that attrition was the main source of bias (<a href="./references#CD006640-fig-0007" title="">Analysis 1.3</a>). The single remaining trial with low risk of attrition bias (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>) found no effects of the intervention. A similar result was seen when trials that used endoscopic therapy to control bleeding were analysed (<a href="./references#CD006640-fig-0008" title="">Analysis 1.4</a>). No difference (test for subgroup differences P value 0.67) was noted between trials published in English and those translated from Russian (<a href="./references#CD006640-fig-0009" title="">Analysis 1.5</a>). </p> <p>One of the trials has been criticised for reporting a high control group event rate (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0037" title="PalmerKR . Non‐variceal upper gastrointestinal haemorrhage: guidelines. Gut2002;Suppl 4:1‐6. ">Palmer 2002</a>). This trial included 516 participants and reported a large weight in the analysis (49%). In a post hoc analysis that excluded this trial, tranexamic acid was seen to have no effect on mortality (RR 0.73, 95% CI 0.45 to 1.19; analysis not shown). In our post hoc trial sequential analysis (<a href="#CD006640-fig-0003">Figure 3</a>), the required information size was not met, suggesting that the meta‐analysis is inconclusive. </p> <div class="figure" id="CD006640-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Trial sequential analysis of eight trials on tranexamic acid versus placebo or no intervention. Outcome measure is mortality. Analysis was performed with alpha 5% and power 80%. Model‐based heterogeneity correction was 0%, relative risk reduction 30% and control group incidence 10%. Graph shows the Z‐curve, which is the cumulative result of analysis with trials added according to year of publication. Horizontal line represents 'traditional' 5% level of significance, and inward sloping red line shows trial sequential monitoring boundary. Vertical line represents required information size. Analysis shows that the Z‐curve crosses the trial sequential monitoring boundary, suggesting that the result of the meta‐analysis is confirmed when analysis is adjusted for cumulative testing. Total number of included participants (N = 1701) is only 62% of required information size (N=2714). The meta‐analysis therefore remains inconclusive." data-id="CD006640-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Trial sequential analysis of eight trials on tranexamic acid versus placebo or no intervention. Outcome measure is mortality. Analysis was performed with alpha 5% and power 80%. Model‐based heterogeneity correction was 0%, relative risk reduction 30% and control group incidence 10%. Graph shows the Z‐curve, which is the cumulative result of analysis with trials added according to year of publication. Horizontal line represents 'traditional' 5% level of significance, and inward sloping red line shows trial sequential monitoring boundary. Vertical line represents required information size. Analysis shows that the Z‐curve crosses the trial sequential monitoring boundary, suggesting that the result of the meta‐analysis is confirmed when analysis is adjusted for cumulative testing. Total number of included participants (N = 1701) is only 62% of required information size (N=2714). The meta‐analysis therefore remains inconclusive. </p> </div> </div> </div> </section> </section> <section id="CD006640-sec-0085"> <h6 class="title">Bleeding</h6> <p>Seven trials reported rebleeding (<a href="./references#CD006640-fig-0010" title="">Analysis 1.6</a>). In total, rebleeding was diagnosed for 117 of 826 participants in the tranexamic acid group and for 146 of 825 participants in the control group. </p> <section id="CD006640-sec-0086"> <p><b>Sensitivity analyses and trial sequential analysis</b></p> <p>The difference was not statistically significant (RR 0.72, 95% CI 0.50 to 1.03; P value 0.07). A similar conclusion was reached in worst‐case scenario analysis (<a href="./references#CD006640-fig-0011" title="">Analysis 1.7</a>) and per‐protocol analysis (data not shown). Analyses of trials with low risk of bias found no effects of tranexamic acid on bleeding (<a href="./references#CD006640-fig-0012" title="">Analysis 1.8</a>), and no differences were noted between trials stratified according to use of endoscopic therapy (<a href="./references#CD006640-fig-0013" title="">Analysis 1.9</a>) or language (<a href="./references#CD006640-fig-0014" title="">Analysis 1.10</a>). In the trial sequential analysis (<a href="#CD006640-fig-0004">Figure 4</a>), 95% of the required information size was reached. This analysis suggested that the meta‐analysis was inconclusive. </p> <div class="figure" id="CD006640-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Trial sequential analysis of seven trials on tranexamic acid versus placebo or no intervention. Outcome measure is bleeding. Analysis was performed with alpha 5% and power 80%. Model‐based heterogeneity correction was 53%, relative risk reduction 30% and control group incidence 10%. Graph shows the Z‐curve, which is the cumulative result of analysis with trials added according to year of publication. Horizontal line represents 'traditional' 5% level of significance, and inward sloping red line shows trial sequential monitoring boundary. Vertical line represents required information size. Analysis shows that the Z‐curve does not cross the trial sequential monitoring boundary, and the total number of participants (N = 1651) is 95% of required information size (N = 1734). The meta‐analysis therefore remains inconclusive." data-id="CD006640-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Trial sequential analysis of seven trials on tranexamic acid versus placebo or no intervention. Outcome measure is bleeding. Analysis was performed with alpha 5% and power 80%. Model‐based heterogeneity correction was 53%, relative risk reduction 30% and control group incidence 10%. Graph shows the Z‐curve, which is the cumulative result of analysis with trials added according to year of publication. Horizontal line represents 'traditional' 5% level of significance, and inward sloping red line shows trial sequential monitoring boundary. Vertical line represents required information size. Analysis shows that the Z‐curve does not cross the trial sequential monitoring boundary, and the total number of participants (N = 1651) is 95% of required information size (N = 1734). The meta‐analysis therefore remains inconclusive. </p> </div> </div> </div> </section> </section> <section id="CD006640-sec-0087"> <h6 class="title">Adverse events</h6> <p>Several participants randomly assigned to tranexamic acid experienced abdominal pain, nausea, vomiting and thrombophlebitis at the injection site (<a href="#CD006640-tbl-0003">Table 1</a>). We were unable to perform meta‐analyses on these adverse events because data were not provided for both treatment and control groups. </p> <div class="table" id="CD006640-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐serious adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐serious adverse events</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tranexamic acid</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention group not specified</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tranexamic acid</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatal stroke (n = 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Confusion <br/> (n = 1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pulmonary embolism (n = 5). Myocardial infarction (n = 8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Confusion (n = 1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0004" title="BiggsJC , HughTB , DoddsAJ . Tranexamic acid and upper gastrointestinal haemorrhage ‐ a double‐blind trial. Gut1976;17:729‐34. ">Biggs 1976</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thrombophlebitis at injection site (n = 3). Nausea or headache (n = 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thrombophlebitis at injection site (n = 2). Nausea or headache (n = 5). Fever (n = 2) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pulmonary embolism (n = 2). Myocardial infarction (n = 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cerebral infarction <br/> (n = 2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Several participants experienced thromboembolic complications. The numbers were described as not significantly different in treatment and control groups, but no specific data are provided </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cerebral infarction <br/> (n = 2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Five additional participants were excluded as the result of thromboembolic disease, but whether these participants were randomly assigned to tranexamic acid or placebo is not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nausea and vomiting, tachycardia (n = 3). Hypotension (n = 3). Thrombophlebitis at injection site (n = 2). Deep venous thrombosis (n = 1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> </tr> </tbody> </table> </div> <p>Three trials (<a href="./references#CD006640-fig-0017" title="">Analysis 1.13</a>) on 1048 participants reported thromboembolic events (<a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a>; <a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a>). Among participants randomly assigned to tranexamic acid, two cases of myocardial infarction, two cases of pulmonary embolism and one case of cerebral infarction occurred. In the placebo group, two cases of myocardial infarction and two cases of cerebral infarction were recorded. When data on these serious thromboembolic events were combined, the difference was not statistically significant (RR 1.37, 95% CI 0.36 to 5.28; <a href="./references#CD006640-fig-0015" title="">Analysis 1.11</a>). Six cases of deep venous thrombosis occurred among participants randomly assigned to tranexamic acid compared with two cases in the placebo group (RR 2.32, 95% CI 0.60 to 8.89; <a href="./references#CD006640-fig-0016" title="">Analysis 1.12</a>). The numbers of participants with any thrombotic event were not significantly different between treatment and control groups (RR 1.86, 95% CI 0.66 to 5.24; <a href="./references#CD006640-fig-0017" title="">Analysis 1.13</a>). </p> </section> </section> <section id="CD006640-sec-0088"> <h5 class="title">Secondary outcomes</h5> <section id="CD006640-sec-0089"> <h6 class="title">Surgery</h6> <p>Seven studies with 1551 participants reported the numbers of participants who required surgery (<a href="./references#CD006640-fig-0018" title="">Analysis 1.14</a>). Between‐trial heterogeneity was important (I² = 63%). Tranexamic acid appeared to reduce the risk of surgery in a fixed‐effect meta‐analysis (RR 0.73, 95% CI 0.56 to 0.95), but this result was no longer statistically significant at the 5% level, when a random‐effects meta‐analysis was used (RR 0.61, 95% CI 0.35 to 1.04; <a href="./references#CD006640-fig-0018" title="">Analysis 1.14</a>). </p> </section> <section id="CD006640-sec-0090"> <h6 class="title">Transfusions</h6> <p>We planned to analyse the transfusion requirements of included participants, but we did not identify the necessary data. We therefore performed a post hoc analysis of the total numbers of participants who needed at least one blood transfusion (<a href="./references#CD006640-fig-0019" title="">Analysis 1.15</a>) and found no apparent differences between tranexamic acid and placebo (RR 1.02, 95% CI 0.94 to 1.11 in 931 participants; five studies; I² = 0%). </p> </section> </section> </section> <section id="CD006640-sec-0091"> <h4 class="title">Comparison 2. Tranexamic acid versus antiulcer drugs (cimetidine or lansoprazole)</h4> <section id="CD006640-sec-0092"> <h5 class="title">Primary outcomes</h5> <section id="CD006640-sec-0093"> <h6 class="title">Mortality and rebleeding</h6> <p>Two trials compared tranexamic acid with cimetidine (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>) or lansoprazole (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). These trials found no significant effects of tranexamic acid on mortality (RR 0.91, 95% CI 0.50 to 1.64; 720 participants; I² = 0%; <a href="./references#CD006640-fig-0020" title="">Analysis 2.1</a>) or bleeding (RR 0.87, 95% CI 0.64 to 1.20; I² = 0%; <a href="./references#CD006640-fig-0021" title="">Analysis 2.2</a>). </p> </section> <section id="CD006640-sec-0094"> <h6 class="title">Adverse events</h6> <p>We were unable to perform meta‐analyses on adverse events (<a href="#CD006640-tbl-0003">Table 1</a>). <a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a> reported one case of fatal stroke in the tranexamic acid group and two cases of confusion in the control group. <a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a> reported no adverse events in the tranexamic acid or control groups. </p> </section> <section id="CD006640-sec-0095"> <h6 class="title">Surgery and transfusions</h6> <p>Trials comparing tranexamic acid versus cimetidine or lansoprazole (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>) found no differences between allocation groups regarding the need for surgery (RR 0.83, 95% CI 0.54 to 1.26; 720 participants; two studies; I² = 3%; <a href="./references#CD006640-fig-0022" title="">Analysis 2.3</a>) or blood transfusion (RR 0.97, 95% CI 0.78 to 1.22; 720 participants; two studies; I² = 64%; <a href="./references#CD006640-fig-0023" title="">Analysis 2.4</a>). </p> </section> </section> </section> <section id="CD006640-sec-0096"> <h4 class="title">'Summary of findings' tables</h4> <p>As shown in the 'Summary of findings' tables on tranexamic acid versus placebo (<a href="./full#CD006640-tbl-0001">summary of findings Table for the main comparison</a>) or cimetidine or lansoprazole (<a href="./full#CD006640-tbl-0002">summary of findings Table 2</a>), the quality of the evidence was downgraded to moderate or low because of risk of bias. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006640-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006640-sec-0097"></div> <section id="CD006640-sec-0098"> <h3 class="title" id="CD006640-sec-0098">Summary of main results</h3> <p>This review includes eight randomised controlled trials and a total of 1701 participants with acute upper gastrointestinal bleeding. The meta‐analyses found that tranexamic acid appears to have a beneficial effect on mortality, but a high dropout rate in some trials means that we cannot be sure of this until additional research is published. Reduced mortality did not clearly reflect reduced bleeding or surgery. The result of the primary meta‐analysis was not stable in analyses that adjusted for risk of attrition bias or in trial sequential analyses. When trials with high risk of attrition bias were removed, only one trial was left (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>) in the analysis, so although we may need to be cautious about the potential effects of dropouts, the evidence is still fairly strong in favour of tranexamic acid. Likewise, only two of the included trials used endoscopic therapy (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>; <a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). These trials found no clear effects of tranexamic acid on bleeding was noted and that attrition bias may affect the assessment of mortality, therefore the combined evidence does not allow any recommendations to be made. Additional randomised controlled trials are needed to determine the effects of tranexamic acid. A large randomised double‐blind trial on tranexamic acid for gastrointestinal bleeding is ongoing (<a href="./references#CD006640-bbs2-0013" title="Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial. ISRCTN2012. ">ISRCTN11225767</a>). This trial has started to randomly assign the first participants. Results of this trial are expected to finally confirm or refute the effects of tranexamic acid for individuals with upper gastrointestinal bleeding. </p> </section> <section id="CD006640-sec-0099"> <h3 class="title" id="CD006640-sec-0099">Overall completeness and applicability of evidence</h3> <p>During recent years, standard care and assessment of outcomes have changed considerably (<a href="./references#CD006640-bbs2-0021" title="DworzynskiK , PollitV , KelseyA , HigginsB , PalmerK . Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ (Clinical Research Edition)2012;344:e3412. [PUBMED: 22695897] ">Dworzynski 2012</a>). Previously, patients were not offered full diagnostic endoscopy or endoscopic interventions that are used as standard care today. It is noteworthy that the trial that is the most favourable towards tranexamic acid was published in 1983 (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>). The clinical question today is not whether tranexamic acid is better than placebo, but whether tranexamic acid is better than or may be used in combination with current treatments. One of the included trials found no significant difference between tranexamic acid and lansoprazole when used alone, or when the two treatments were combined (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). This trial was not designed to assess clinical outcomes, and its statistical power may well have been too small to detect clinically relevant effects. On the other hand, this trial does suggest that additional research is necessary. </p> <p>Several reasons may explain why we found that tranexamic acid reduces mortality but not bleeding. One possible explanation is that tranexamic acid may be effective in subgroups of patients with a serious prognosis. One of the included trials assessed the influence of the severity of bleeding on the intervention effect (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). This trial included 414 participants with suspected upper gastrointestinal bleeding and asked admitting investigators to classify participant risk as high or low on the basis of their presentation. No specific criteria were used. Overall, high‐risk participants were more likely to die or need surgery. The effect of tranexamic acid was not related to risk stratification. </p> </section> <section id="CD006640-sec-0100"> <h3 class="title" id="CD006640-sec-0100">Quality of the evidence</h3> <p>In clinical guidelines on the management of upper gastrointestinal non‐variceal bleeding, tranexamic acid may be considered, but it is not recommended as routine therapy (<a href="./references#CD006640-bbs2-0037" title="PalmerKR . Non‐variceal upper gastrointestinal haemorrhage: guidelines. Gut2002;Suppl 4:1‐6. ">Palmer 2002</a>; <a href="./references#CD006640-bbs2-0015" title="BarkunA , BardouM , MarshallJK , Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Annals of Internal Medicine2003;139:843‐57. ">Barkun 2003</a>). This treatment generally is not recommended for variceal bleeding, and in several trials, participants with varices were excluded after randomisation. However, meta‐analyses in the present review include participants with upper gastrointestinal bleeding due to oesophageal varices. No significant association was found between treatment effect and the proportion of participants with varices. These analyses are only hypothesis generating but suggest that the effects of tranexamic acid on mortality may also be seen in this patient group. Likewise, we found no significant differences between trials in which participants received tranexamic acid in a daily dose of 12 g for two days and those in which the dose was 4 g for seven days. It may be interesting to determine whether dose or treatment duration is related to the risk of thromboembolic events, but we did not have sufficient data to analyse this question. </p> <p>Vested interests were reported in some of the included trials. We were unable to identify specific design features that introduced bias due to vested interests and the fact that we included only eight trials limited the possibility of further analyses. Nevertheless, we cannot exclude that this factor can lead to bias. On the other hand, the trial that received full funding (<a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>) found no effect of tranexamic acid on any of the outcomes assessed.The largest trials received tranexamic acid and placebo from pharmaceutical companies (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>; <a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a>). The trial with the most positive assessment of tranexamic acid received only medications (<a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a>). </p> <p>Mortality is an outcome measure that is relatively stable in relation to performance and ascertainment bias, but not to attrition bias. We found that attrition was the main source of bias. Included trials randomly assigned participants early, and many excluded participants after the source of bleeding had been identified by endoscopy. Exclusion of participants appeared to be done before blinding was broken, although this is not specifically stated. As the result of risk of bias and clinical heterogeneity between trials, which is inevitable given that trials were conducted over several decades, the overall quality of the evidence was deemed moderate or low (<a href="./full#CD006640-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD006640-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD006640-sec-0101"> <h3 class="title" id="CD006640-sec-0101">Potential biases in the review process</h3> <p>Potential biases in the review process are limited. In particular, we attempted to avoid bias in identification and selection of trials, but one possible limitation is that despite exhaustive searching, it is possible that other trials have been conducted, and although we searched extensively, we did not identify unpublished trials or trials published in abstract form. We included only one paper that was published in Russian (<a href="./references#CD006640-bbs2-0001" title="BagnenkoSF , VerbitskiiVG . [Antifibrinolitic therapy for the treatment of massive ulcerative gastro‐intestinal bleedings]. Khirurgiia2011;4:42‐6. [PUBMED: 21721282] ">Bagnenko 2011</a>). Remaining trials were published in English. Because the number of identified trials was limited, we were not able to analyse the risk of publication bias. In theory, meta‐analyses are observational, which may lead to biases. A written protocol is necessary to determine biases in the review process and in general, the original protocol must be followed. However, we made methodological changes to our protocol that were based on recent evidence and guidelines (<a href="./references#CD006640-bbs2-0024" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical Research Edition)2008;336(7650):924‐6. [PUBMED: 18436948] ">Guyatt 2008</a>; <a href="./references#CD006640-bbs2-0028" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Colloboration, 2008. www.cochrane‐handbook.org. ">Higgins 2008</a>; <a href="./references#CD006640-bbs2-0029" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). These changes were mainly related to assessment of risk of bias. We also performed post hoc sequential analyses to improve assessment of biases. </p> </section> <section id="CD006640-sec-0102"> <h3 class="title" id="CD006640-sec-0102">Agreements and disagreements with other studies or reviews</h3> <p>Although our review methods did include assessment of all reported adverse events, we did not carry out a separate search for adverse effects; therefore one of the most important limitations of the present review is the fact that information about adverse events was limited. The recent debate on the use of antifibrinolytic drugs highlights the need for valid safety data. In 2006, an observational study of patients undergoing revascularisation was reported (<a href="./references#CD006640-bbs2-0034" title="ManganoDT , TudorIC , DietzelC . The risk associated with aprotinin in cardiac surgery. The New England Journal of Medicine2006;354:353‐65. ">Mangano 2006</a>). This study included 1295 participants who received aprotinin and 822 who received tranexamic acid. Multi‐variable analyses found that aprotinin, but not tranexamic acid, significantly increased the risk of renal failure and cardiovascular or cerebral adverse events. Although results support the safety of tranexamic acid, the participant cohort was considerably different from that included in the present review. In particular, the trials included in the present review excluded participants with previous thromboembolic or renal disease. Therefore, it may be argued that one of the most important limitations of the present review is that limited information about adverse events was available. Although we found no significant association between tranexamic acid and risk of thromboembolic events, our analyses did not have sufficient statistical power to allow clear inferences. Theoretically, tranexamic acid increases the risk of thrombosis due to unopposed fibrin generation. Case reports have associated tranexamic acid with thromboembolic events, which may be fatal (<a href="./references#CD006640-bbs2-0041" title="RydinE , LundbergPO . Tranexamic acid and intracranial thrombosis. Lancet1976;2:49. ">Rydin 1976</a>; <a href="./references#CD006640-bbs2-0014" title="AgnelliG , GreseleP , DeCuntoM , GallaiV , NenciGG . Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report. British Journal of Obstetrics and Gynaecology1982;89:681‐2. ">Agnelli 1982</a>; <a href="./references#CD006640-bbs2-0022" title="EndoY , NishimuraS , MiuraA . Deep‐vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura. JAMA1988;259:3561‐2. ">Endo 1988</a>; <a href="./references#CD006640-bbs2-0046" title="WooKS , TseLK , WooJL , Vallance‐OwenJ . Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy. British Journal of Clinical Practice1989;43:465‐6. ">Woo 1989</a>; <a href="./references#CD006640-bbs2-0042" title="TapariaM , CordingleyFT , LeahyMF . Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. European Journal of Haematology2002;68:307‐9. ">Taparia 2002</a>). The trials in the present review excluded participants with previous thromboembolic events, although this is not generally accepted as a contraindication in clinical practice. Likewise these trials excluded participants with renal disease. One observational study has assessed the effects of tranexamic acid on patients undergoing dialysis. Tranexamic acid seems relatively safe to use in this patient group. However, the study included only 20 participants, so additional evidence is needed (<a href="./references#CD006640-bbs2-0011" title="SabovicM , LavreJ , VujkovacB . Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrology, Dialysis, Transplantation2003;18:1388‐91. ">Sabovic 2003</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006640-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006640-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006640-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of eight trials on tranexamic acid versus placebo or no intervention. Outcome measure is mortality. Analysis was performed with alpha 5% and power 80%. Model‐based heterogeneity correction was 0%, relative risk reduction 30% and control group incidence 10%. Graph shows the Z‐curve, which is the cumulative result of analysis with trials added according to year of publication. Horizontal line represents 'traditional' 5% level of significance, and inward sloping red line shows trial sequential monitoring boundary. Vertical line represents required information size. Analysis shows that the Z‐curve crosses the trial sequential monitoring boundary, suggesting that the result of the meta‐analysis is confirmed when analysis is adjusted for cumulative testing. Total number of included participants (N = 1701) is only 62% of required information size (N=2714). The meta‐analysis therefore remains inconclusive." data-id="CD006640-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Trial sequential analysis of eight trials on tranexamic acid versus placebo or no intervention. Outcome measure is mortality. Analysis was performed with alpha 5% and power 80%. Model‐based heterogeneity correction was 0%, relative risk reduction 30% and control group incidence 10%. Graph shows the Z‐curve, which is the cumulative result of analysis with trials added according to year of publication. Horizontal line represents 'traditional' 5% level of significance, and inward sloping red line shows trial sequential monitoring boundary. Vertical line represents required information size. Analysis shows that the Z‐curve crosses the trial sequential monitoring boundary, suggesting that the result of the meta‐analysis is confirmed when analysis is adjusted for cumulative testing. Total number of included participants (N = 1701) is only 62% of required information size (N=2714). The meta‐analysis therefore remains inconclusive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of seven trials on tranexamic acid versus placebo or no intervention. Outcome measure is bleeding. Analysis was performed with alpha 5% and power 80%. Model‐based heterogeneity correction was 53%, relative risk reduction 30% and control group incidence 10%. Graph shows the Z‐curve, which is the cumulative result of analysis with trials added according to year of publication. Horizontal line represents 'traditional' 5% level of significance, and inward sloping red line shows trial sequential monitoring boundary. Vertical line represents required information size. Analysis shows that the Z‐curve does not cross the trial sequential monitoring boundary, and the total number of participants (N = 1651) is 95% of required information size (N = 1734). The meta‐analysis therefore remains inconclusive." data-id="CD006640-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Trial sequential analysis of seven trials on tranexamic acid versus placebo or no intervention. Outcome measure is bleeding. Analysis was performed with alpha 5% and power 80%. Model‐based heterogeneity correction was 53%, relative risk reduction 30% and control group incidence 10%. Graph shows the Z‐curve, which is the cumulative result of analysis with trials added according to year of publication. Horizontal line represents 'traditional' 5% level of significance, and inward sloping red line shows trial sequential monitoring boundary. Vertical line represents required information size. Analysis shows that the Z‐curve does not cross the trial sequential monitoring boundary, and the total number of participants (N = 1651) is 95% of required information size (N = 1734). The meta‐analysis therefore remains inconclusive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 1 Mortality." data-id="CD006640-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 2 Mortality scenario analysis, treatment failure if participant missing." data-id="CD006640-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 2 Mortality scenario analysis, treatment failure if participant missing. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 3 Mortality in trials with low risk of bias." data-id="CD006640-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 3 Mortality in trials with low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 4 Mortality in relation to endoscopic therapy." data-id="CD006640-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 4 Mortality in relation to endoscopic therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 5 Mortality in relation to language of publication." data-id="CD006640-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 5 Mortality in relation to language of publication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 6 Rebleeding." data-id="CD006640-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 6 Rebleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 7 Rebleeding scenario analysis, treatment failure if participant missing." data-id="CD006640-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 7 Rebleeding scenario analysis, treatment failure if participant missing. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 8 Rebleeding in trials with low risk of bias." data-id="CD006640-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 8 Rebleeding in trials with low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 9 Rebleeding in relation to endoscopic therapy." data-id="CD006640-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 9 Rebleeding in relation to endoscopic therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 10 Rebleeding in relation to language of publication." data-id="CD006640-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 10 Rebleeding in relation to language of publication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 11 Myocardial infarction, pulmonary embolism and cerebral infarction." data-id="CD006640-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 11 Myocardial infarction, pulmonary embolism and cerebral infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 12 Deep venous thrombosis." data-id="CD006640-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 12 Deep venous thrombosis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 13 Any thromboembolic event." data-id="CD006640-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 13 Any thromboembolic event.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 14 Surgery." data-id="CD006640-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 14 Surgery.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Tranexamic acid vs placebo, Outcome 15 Transfusion required." data-id="CD006640-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Tranexamic acid vs placebo, Outcome 15 Transfusion required.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Tranexamic acid vs cimetidine or lansoprazole, Outcome 1 Mortality." data-id="CD006640-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Tranexamic acid vs cimetidine or lansoprazole, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Tranexamic acid vs cimetidine or lansoprazole, Outcome 2 Bleeding." data-id="CD006640-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Tranexamic acid vs cimetidine or lansoprazole, Outcome 2 Bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Tranexamic acid vs cimetidine or lansoprazole, Outcome 3 Surgery." data-id="CD006640-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Tranexamic acid vs cimetidine or lansoprazole, Outcome 3 Surgery.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006640-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/urn:x-wiley:14651858:media:CD006640:CD006640-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_t/tCD006640-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Tranexamic acid vs cimetidine or lansoprazole, Outcome 4 Transfusion." data-id="CD006640-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Tranexamic acid vs cimetidine or lansoprazole, Outcome 4 Transfusion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/media/CDSR/CD006640/image_n/nCD006640-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006640-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Tranexamic acid vs placebo for upper gastrointestinal bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Tranexamic acid vs placebo for upper gastrointestinal bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with upper gastrointestinal bleeding<br/> <b>Settings:</b> <br/> <b>Intervention:</b> tranexamic acid vs placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Tranexamic acid vs placebo</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality</b> <br/> Clinical<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.6</b> <br/> (0.42‐0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1701<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> <br/> (34‐72) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> <br/> (34‐71) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Rebleeding</b> <br/> Clinical and endoscopic assessment<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.72</b> <br/> (0.50‐1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1651<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>177 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>142 per 1000</b> <br/> (113‐177) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>196 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>157 per 1000</b> <br/> (125‐196) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Any thromboembolic event</b> <br/> Clinical and radiological assessment<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.86</b> <br/> (0.66‐5.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1095<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> <br/> (7‐57) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> <br/> (7‐52) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Surgery</b> <br/> Number of participants who underwent surgery<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.61</b> <br/> (0.35‐1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1551<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>142 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> <br/> (79‐135) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>154 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>112 per 1000</b> <br/> (86‐146) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Transfusion</b> <br/> Number needing blood transfusion<br/> Follow‐up: median 3 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.02</b> <br/> (0.94‐1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>931<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>564 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>558 per 1000</b> <br/> (507‐620) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>583 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>577 per 1000</b> <br/> (525‐641) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Most trials had high risk of attrition bias.<br/> <sup>b</sup>Not possible to evaluate because number of trials was limited.<br/> <sup>c</sup>Statistical between‐trial heterogeneity approached 50%.<br/> <sup>d</sup>The number of participants who needed transfusion is an indirect measure of bleeding and varies among clinical sites. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Tranexamic acid vs placebo for upper gastrointestinal bleeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006640-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Tranexamic acid vs cimetidine or lansoprazole for upper gastrointestinal bleeding</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Tranexamic acid vs cimetidine or lansoprazole for upper gastrointestinal bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with upper gastrointestinal bleeding<br/> <b>Settings:</b> <br/> <b>Intervention:</b> tranexamic acid vs cimetidine or lansoprazole </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Tranexamic acid vs cimetidine or lansoprazole</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality</b> <br/> Number of participants who died<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.91</b> <br/> (0.50‐1.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>720<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> <br/> (31‐101) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b> <br/> (24‐79) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Rebleeding</b> <br/> Clinical and endoscopic assessment<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.87</b> <br/> (0.64‐1.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>720<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>188 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>166 per 1000</b> <br/> (121‐226) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>161 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>142 per 1000</b> <br/> (103‐193) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Surgery</b> <br/> Number of participants who underwent surgery<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.83</b> <br/> (0.54‐1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>720<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>139 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>115 per 1000</b> <br/> (79‐168) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>87 per 1000</b> <br/> (60‐127) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Transfusion</b> <br/> Number of participants who required at least 1 blood transfusion<br/> Follow‐up: median 5 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.97</b> <br/> (0.78‐1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>720<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>573 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>579 per 1000</b> <br/> (510‐654) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>599 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>605 per 1000</b> <br/> (533‐683) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>High risk of bias based on assessment of attrition.<br/> <sup>b</sup>Not possible to evaluate because number of trials was limited.<br/> <sup>c</sup>This outcome measure is a surrogate estimate for bleeding. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Tranexamic acid vs cimetidine or lansoprazole for upper gastrointestinal bleeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006640-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐serious adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐serious adverse events</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tranexamic acid</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention group not specified</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tranexamic acid</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0002" title="BarerD , OgilvieA , HenryD , DronfieldM , CoggonD , FrenchS , et al. Cimetidine and tranexamic acid in the treatment of acute upper‐gastrointestinal‐tract bleeding. New England Journal of Medicine1983;308:1571‐5. OgilvieAL , BarerD , DronfieldMW . Trial of cimetidine, tranexamic acid and placebo in the management of acute upper gastrointestinal haemorrhage [abstract]. Gut1981;22:F20. ">Barer 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatal stroke (n = 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Confusion <br/> (n = 1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pulmonary embolism (n = 5). Myocardial infarction (n = 8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Confusion (n = 1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0004" title="BiggsJC , HughTB , DoddsAJ . Tranexamic acid and upper gastrointestinal haemorrhage ‐ a double‐blind trial. Gut1976;17:729‐34. ">Biggs 1976</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thrombophlebitis at injection site (n = 3). Nausea or headache (n = 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thrombophlebitis at injection site (n = 2). Nausea or headache (n = 5). Fever (n = 2) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0006" title="EngqvistA , BrostromO , vonFeilitzenF , HalldinM , NystromB , OstA , et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double‐blind study. Scandinavian Journal of Gastroenterology1979;14:839‐44. ">Engquist 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pulmonary embolism (n = 2). Myocardial infarction (n = 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cerebral infarction <br/> (n = 2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0007" title="HawkeyGM , ColeAT , McIntyreAS , LongRG , HawkeyCJ . Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut2001;49:372‐9. ">Hawkey 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Several participants experienced thromboembolic complications. The numbers were described as not significantly different in treatment and control groups, but no specific data are provided </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006640-bbs2-0008" title="vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ (Clinical Research Edition)1987;294:7‐10. vonHolsteinCC , ErikssonSB , KallenR . Tranexamic acid in gastric and duodenal bleeding. Scandinavian Journal of Gastroenterology. Supplement1987;137:71‐4. ">Holstein 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cerebral infarction <br/> (n = 2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Five additional participants were excluded as the result of thromboembolic disease, but whether these participants were randomly assigned to tranexamic acid or placebo is not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nausea and vomiting, tachycardia (n = 3). Hypotension (n = 3). Thrombophlebitis at injection site (n = 2). Deep venous thrombosis (n = 1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None described</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/full#CD006640-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006640-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Tranexamic acid vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1701</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.42, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality scenario analysis, treatment failure if participant missing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1701</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.43, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality in trials with low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Allocation sequence generation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.26, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1654</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.42, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Blinding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1654</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.42, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Incomplete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.22, 2.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.41, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mortality in relation to endoscopic therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1701</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.42, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Endoscopic therapy not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.40, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Endoscopic therapy used to control bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.22, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mortality in relation to language of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1701</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.42, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Trials published in English</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1654</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.42, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Trials translated from Russian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.04, 3.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Rebleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.50, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Rebleeding scenario analysis, treatment failure if participant missing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.51, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Rebleeding in trials with low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.65, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Allocation sequence generation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.83, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1604</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.50, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Blinding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1604</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.50, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Incomplete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.9 [0.38, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5 Selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.50, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Rebleeding in relation to endoscopic therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.50, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Endoscopic therapy not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.45, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Endoscopic therapy used to control bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.36, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Rebleeding in relation to language of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.50, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Trials published in English</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1604</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.50, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Trials translated from Russian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.10, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Myocardial infarction, pulmonary embolism and cerebral infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1048</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.36, 5.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Deep venous thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1048</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [0.60, 8.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Any thromboembolic event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [0.66, 5.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.35, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Transfusion required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>931</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.94, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Tranexamic acid vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006640-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Tranexamic acid vs cimetidine or lansoprazole</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.50, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.64, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.54, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Transfusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.78, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Tranexamic acid vs cimetidine or lansoprazole</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006640.pub3/references#CD006640-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006640.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006640-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006640-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006640-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD006640-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD006640-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006640-note-0001">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006640\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006640\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006640\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006640\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006640\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006640.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006640.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006640.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006640.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006640.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718231805"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006640.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718231809"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006640.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcb4b397af3fd',t:'MTc0MDcxODIzMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 